HSV-1 inhibitors (ViRAZE/Fox Chase Chemical Diversity Center)

N/A

Report date: 2025/01/26 19:26:25
NME

Base Information

Drug NameHSV-1 inhibitors (ViRAZE/Fox Chase Chemical Diversity Center)
Drug Alias NameVIR-003 (ViRAZE)Z-9445
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsHerpes Simplex Virus Type 1 InfectionsKeratitis, Herpetic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesViraze
China Registration ClassN/A

Develop Information

Active CompaniesVirazeFox Chase Chemical Diversity Center Inc
Inactive CompaniesN/A
Active IndicationsHerpes Simplex Virus Type 1 InfectionsKeratitis, Herpetic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A